The mechanism represents an entirely new strategy for producing light, opening the door to flexible, environmentally friendly optical materials,” it said. “One of the material’s most significant ...
Month Phase 2 data in High-Risk NMIBC to be presented Friday, May 15, 2026Phase 3 overview to be presented at Trials-in-Progress session on ...
18h
Artiva Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights
Initial AlloNK® (AB-101) clinical data demonstrated 71% ACR50 response in refractory rheumatoid arthritis (RA) patients with at least six months ...
On February 27th America’s president walloped the “leftwing nut jobs” of Anthropic, an American AI lab that works with the ...
Creatv Bio, a Division of Creatv MicroTech, Inc. ("Creatv"), a cancer diagnostic blood testing company, is pleased to announce one poster presentation and four poster abstracts in conjunction with ...
Writer Jon Krakauer was there as a client of Kiwi Rob Hall’s Adventure Consultants on assignment for Outside, and the ...
NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALFNL), a biopharmaceutical company developing innovative botanical drugs for the treatment of addictions, announces that its work on NFL-102, ...
Initial clinical data demonstrated 71% ACR50 response in refractory rheumatoid arthritis (RA) patients with at least six months of follow-up in the company-sponsored Phase 2a basket trial, with no pat ...
Driven by constant tech breakthroughs and growing market adoption, humanoid robots in China are undergoing a notable wave of ...
This has materialized as actual protests from groups including Everyone Hates Elon (as in Musk), which over the past few ...
On April 24, over a hundred KU architecture and design students showcased studio work in KC Design Week. Three students sat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results